|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.590 CNY | +2.29% |
|
-4.41% | -4.41% |
| Market Cap | 4.42B 652M 564M 519M 486M 911M 62.01B 925M 6.13B 2.39B 30.18B 2.45B 2.4B 105B | P/E Ratio 2024 |
207x | P/E Ratio 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.25B 627M 542M 499M 467M 876M 59.64B 890M 5.9B 2.3B 29.03B 2.35B 2.3B 101B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +2.29% | ||
| 1 week | -4.41% | ||
| Current month | -7.44% | ||
| 1 month | -18.82% | ||
| 3 months | -28.40% | ||
| 6 months | -4.65% | ||
| Current year | -4.41% |
| 1 week | 7.33 |  | 7.96 |
| 1 month | 7.33 | | 9.14 |
| Current year | 7.33 | | 11.38 |
| 1 year | 7.33 | | 11.98 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 15.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 2017-12-10 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 2019-07-31 |
Sen Li
COO | Chief Operating Officer | 45 | 2022-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 2019-07-31 |
Ying Yang
CHM | Chairman | 48 | 2019-03-20 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 2019-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | -4.41% | -10.60% | +14.14% | 652M | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| Average | +0.44% | +0.67% | +15.98% | +42.26% | 342.96B | |
| Weighted average by Cap. | -0.23% | +1.03% | +27.76% | +70.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 145M 126M 116M 108M 203M 13.82B 206M 1.37B 533M 6.72B 545M 534M 23.28B | 1.21B 178M 154M 142M 133M 249M 16.93B 253M 1.67B 653M 8.24B 668M 654M 28.53B |
| Net income | 13.65M 2.02M 1.74M 1.61M 1.5M 2.82M 192M 2.86M 18.96M 7.39M 93.33M 7.57M 7.41M 323M | 92.73M 13.7M 11.84M 10.91M 10.21M 19.13M 1.3B 19.43M 129M 50.21M 634M 51.43M 50.34M 2.2B |
| Net Debt | 189M 27.94M 24.13M 22.24M 20.82M 39.01M 2.66B 39.62M 263M 102M 1.29B 105M 103M 4.48B | -169M -24.95M -21.55M -19.85M -18.58M -34.83M -2.37B -35.37M -234M -91.41M -1.15B -93.62M -91.63M -4B |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 7.590 ¥ | +2.29% | 11,803,700 |
| 26-06-11 | 7.420 ¥ | -1.98% | 8,779,800 |
| 26-06-10 | 7.570 ¥ | -1.82% | 9,839,450 |
| 26-06-09 | 7.710 ¥ | +0.65% | 9,096,000 |
| 26-06-08 | 7.660 ¥ | -3.53% | 12,347,050 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
